Stock Analysis
Oscar Health, Inc. (OSCR) Stock Analysis
Oscar Health, Inc. (OSCR) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Oscar Health, Inc. (OSCR) currently has an AIQ Score of 57/100, indicating a neutral setup. Quality is the strongest factor at 86/100. Risk is the weakest current factor at 30/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
OSCR at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $30.37 |
| AIQ Score | 57/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $7.73B |
| P/E Ratio (TTM) | 17.44 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.20 |
| Revenue (quarter ended 2026-06-30) | $4.88B |
| Dividend Yield (TTM) | 0.00% |
| Beta | 2.39 |
| Volume | 3.64M |
| 52-week range | $10.69-$35.01 |
| RSI 14 | 36.84 |
| 50-Day SMA | $31.74 |
| 200-Day SMA | $23.53 |
| Analyst Price Target | $32.94 |
| Next Earnings | Nov 5, 2026 |
OSCROscar Health, Inc.
Healthcare / Medical - Healthcare Plans
Low Priority
Above Peers
Latest quote
- Momentum36
- Value59
- Quality86
- Risk resilience30
- Sentiment—
OSCR Stock Analysis Summary
Oscar Health, Inc. (OSCR) currently has an AIQ Score of 57/100, indicating a neutral setup. Quality is the strongest factor at 86/100. Risk resilience is the weakest current factor at 30/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, OSCR has AIQ Score of 57/100 with Quality base of 86/100 and fading Risk resilience at 30/100. Wait for component alignment before adding exposure.
Quality (86/100) leads while Risk resilience (30/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -1.36% stock move · OSCR classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is OSCR Bullish or Bearish Right Now?
OSCR currently has a neutral overall setup. Quality is the strongest factor at 86/100, while Risk Resilience is weakest at 30/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 86/100.
- - Analyst target implies +8.46% upside from the latest quote.
- - Momentum is weak at 36/100.
- - Risk Resilience is weak at 30/100.
- - Technical consensus has more sell votes than buy votes (28 vs 13).
Current Consensus
OSCR's Technical Analysis Consensus is currently Sell, with 13 buy, 4 neutral, and 28 sell votes. OSCR's 14-day RSI is 36.84, which places the stock in a weaker momentum range. OSCR's beta is 2.39, indicating greater market sensitivity than the broad market.
What Changed in OSCR?
The largest recent change in OSCR is Momentum moving down by 37.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.
What Would Change the OSCR Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
OSCR Decision Framework
Public evidence layers, setup checks, and risk context for Oscar Health, Inc..
Oscar Health, Inc. (OSCR) Stock Analysis
Oscar Health, Inc. has an AIQ Score of 57/100 in a Neutral regime. Quality is strongest at 86/100. Beta is 2.47, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | OSCR is in a Neutral AIQ regime with score 57/100. |
| Signal Conflict | The primary conflict is that quality leads at 86/100 while risk lags at 30/100. |
| Factor Evidence | Momentum 36/100 · Value 59/100 · Quality 86/100 · Risk 30/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 86/100.
Momentum is 36/100 and RSI (14) is 36.8.
OSCR is in a Neutral regime at 57/100.
Risk factor is 30/100 with beta 2.47 and annual volatility 67.19%.
Current conflict: quality leads at 86/100 while risk lags at 30/100.
OSCR Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
OSCR Fundamentals
OSCR valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
OSCR Technical Analysis
OSCR technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
OSCR Stock Catalysts
Track OSCR earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
OSCR Dividend Analysis
OSCR dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
OSCR Financial Data
OSCR revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
OSCR Risk Analysis
OSCR volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
OSCR Stock News
OSCR stock news, market tone, recent headlines, and catalyst context.
OSCR vs Healthcare Services / Managed Care Peers
Current peer cohort: OSCR · PGNY · PHR · PRVA · TDOC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| OSCR Current stock | 57/100 | 59/100 | 36/100 | 30/100 | 1 | 67.19% | Current |
| PGNY Progyny | 59/100 | 51/100 | 65/100 | 70/100 | 0.93 | 54.37% | OSCR vs PGNY |
| PHR Phreesia | 59/100 | 42/100 | 79/100 | 59/100 | -0.81 | 58.58% | OSCR vs PHR |
| PRVA Privia Health | 49/100 | 42/100 | 65/100 | 69/100 | -0.44 | 32.13% | OSCR vs PRVA |
| TDOC Teladoc Health | 57/100 | 65/100 | 79/100 | 21/100 | 0.36 | 65.76% | OSCR vs TDOC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching OSCR
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for OSCR
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
OSCR Stock FAQ
What is OSCR stock price today?
Oscar Health, Inc.'s current stock price is $30.37. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is OSCR bullish or bearish right now?
OSCR's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is OSCR's market cap?
OSCR's market cap is $7.73B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is OSCR's current P/E ratio?
OSCR's current P/E ratio is 17.44 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is OSCR's RSI?
OSCR's 14-day RSI is 36.84 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is OSCR above its 50-day and 200-day moving averages?
OSCR is -2.99% from its 50-day SMA and 30.84% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is OSCR's next earnings date?
OSCR's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does OSCR pay a dividend?
OSCR's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.